scholarly journals Injecting Patent Blue Dye V for sentinel lymph node biopsy without skin staining

2012 ◽  
Vol 94 (4) ◽  
pp. 277-278
Author(s):  
S Johnson ◽  
S Arora ◽  
E Babu
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Lymph Node Biopsy ◽  
Blue Dye ◽  
Patent Blue ◽  
Node Biopsy ◽  
Patent Blue Dye

scholarly journals How Long Will I Be Blue? Prolonged Skin Staining Following Sentinel Lymph Node Biopsy Using Intradermal Patent Blue Dye

Breast Care ◽  
2013 ◽  
Vol 8 (3) ◽  
pp. 199-202 ◽  
Author(s):  
Metehan Gumus ◽  
Hatice Gumus ◽  
Sue E Jones ◽  
Peter A Jones ◽  
Ali R Sever ◽  
...  
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Lymph Node Biopsy ◽  
Blue Dye ◽  
Patent Blue ◽  
Node Biopsy ◽  
Patent Blue Dye

scholarly journals Atypical Anaphylactic Reaction to Patent Blue During Sentinel Lymph Node Biopsy for Breast Cancer

2008 ◽  
Vol 90 (4) ◽  
pp. 338-339 ◽  
Author(s):  
Sophocles Lanitis ◽  
George Filippakis ◽  
Virinder Sidhu ◽  
Ragheed AL Mufti ◽  
Tak H Lee ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Lymph Node Biopsy ◽  
Skin Tests ◽  
Blue Dye ◽  
Patent Blue ◽  
Node Biopsy ◽  
Patent Blue Dye

INTRODUCTION We present an unusual case of severe anaphylaxis to Patent Blue dye with atypical clinical features during sentinel lymph node biopsy (SLNB). The medical personnel involved with sentinel node biopsies should be alert, and familiar with this unusual entity. We also present current data from the literature. CASE REPORT During a wide local excision for primary breast cancer and SLNB, and early during the operation, the patient became severely tachycardic and hypotensive without any signs of urticaria, rash, oedema, or bronchospasm. Resuscitation required the addition of noradrenaline infusion followed by an overnight admission to the intensive care unit. Raised serum tryptase levels supported the diagnosis of anaphylactic shock while skin tests showed a severe reaction to Patent Blue dye. CONCLUSIONS Severe, life-threatening anaphylaxis to Patent Blue dye may present without obvious previous exposure to the dye and without the cardinal signs of oedema, urticaria and bronchospasm making the diagnosis and management of such cases challenging. Correct diagnosis and identification of the causative factor is important and requires a specific set of laboratory tests that are not commonly requested in every-day medical practice. It is not clear from the literature whether the condition is common enough to justify pre-operative prophylactic or diagnostic measures.

Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer

2001 ◽  
Vol 27 (2) ◽  
pp. 218-219 ◽  
Author(s):  
M.H. Mullan ◽  
S.J. Deacock ◽  
N.F. Quiney ◽  
M.W. Kissin
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Lymph Node Biopsy ◽  
Blue Dye ◽  
Patent Blue ◽  
Node Biopsy ◽  
Patent Blue Dye

Kounis syndrome after patent blue dye injection for sentinel lymph node biopsy

Breast Cancer ◽  
2020 ◽  
Vol 27 (6) ◽  
pp. 1191-1197
Author(s):  
Maximos Frountzas ◽  
Panagiotis Karathanasis ◽  
Gavriella Zoi Vrakopoulou ◽  
Charalampos Theodoropoulos ◽  
Constantinos G. Zografos ◽  
...  
Keyword(s):  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Lymph Node Biopsy ◽  
Blue Dye ◽  
Kounis Syndrome ◽  
Patent Blue ◽  
Node Biopsy ◽  
Patent Blue Dye
Sign in / Sign up

Export Citation Format

Share Document